TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing


Saturday, September 28th 2024

Loeb S, Keith SW, Cheng HH, Leader AE, Gross L, Sanchez Nolasco T, Byrne N, Hartman R, Brown LH, Pieczonka CM, Gomella LG, Kelly WK, Lallas CD, Handley N, Mille PJ, Mark JR, Brown GA, Chopra S, McClellan A, Wise DR, Hollifield L, Giri VN.

“TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing”

JCO Precis Oncol. 2024 Mar;8:e2300552.

Link: https://pubmed.ncbi.nlm.nih.gov/38452310/

In this randomized clinical trial, we found that pre-test genetic education through a patient-driven webtool was non-inferior to traditional genetic counseling.

Comments are closed.